Related references
Note: Only part of the references are listed.Arsenic affects homologous recombination and single-strand annealing but not end-joining pathways during DNA double-strand break repair
Aya Kurosawa et al.
FEBS JOURNAL (2023)
GLUT3 inhibitor discovery through in silico ligand screening and in vivo validation in eukaryotic expression systems
Cristina Iancu et al.
SCIENTIFIC REPORTS (2022)
Glutor, a Glucose Transporter Inhibitor, Exerts Antineoplastic Action on Tumor Cells of Thymic Origin: Implication of Modulated Metabolism, Survival, Oxidative Stress, Mitochondrial Membrane Potential, pH Homeostasis, and Chemosensitivity
Mithlesh Kumar Temre et al.
FRONTIERS IN ONCOLOGY (2022)
GLUT3 Promotes Epithelial-Mesenchymal Transition via TGF-β/JNK/ATF2 Signaling Pathway in Colorectal Cancer Cells
Moon-Young Song et al.
BIOMEDICINES (2022)
An appraisal of the current status of inhibition of glucose transporters as an emerging antineoplastic approach: Promising potential of new pan-GLUT inhibitors
Mithlesh Kumar Temre et al.
FRONTIERS IN PHARMACOLOGY (2022)
A simple protocol to isolate a single human cell PRDX1 knockout generated by CRISPR-Cas9 system
Mustapha Aouida et al.
STAR PROTOCOLS (2022)
The base excision repair process: comparison between higher and lower eukaryotes
Nagham Nafiz Hindi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Overexpression of GLUT3 promotes metastasis of triple-negative breast cancer by modulating the inflammatory tumor microenvironment
Tai-Hua Tsai et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
Arsenic-protein interactions as a mechanism of arsenic toxicity
Cristian A. Vergara-Geronimo et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2021)
PRDX1 activates autophagy via the PTEN-AKT signaling pathway to protect against cisplatin-induced spiral ganglion neuron damage
Wenwen Liu et al.
AUTOPHAGY (2021)
A small-molecule pan-class I glucose transporter inhibitor reduces cancer cell proliferation in vitro and tumor growth in vivo by targeting glucose-based metabolism
Pratik Shriwas et al.
CANCER & METABOLISM (2021)
An Overview of Cell-Based Assay Platforms for the Solute Carrier Family of Transporters
Vojtech Dvorak et al.
FRONTIERS IN PHARMACOLOGY (2021)
Glucose Transporters as a Target for Anticancer Therapy
Monika Pliszka et al.
CANCERS (2021)
PRDX1 is essential for the viability and maintenance of reactive oxygen species in chicken DT40
Takahito Moriwaki et al.
GENES AND ENVIRONMENT (2021)
A role for GLUT3 in glioblastoma cell invasion that is not recapitulated by GLUT1
Catherine J. Libby et al.
CELL ADHESION & MIGRATION (2021)
The solute carrier transporters and the brain: Physiological and pharmacological implications
Chengliang Hu et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Metabolic Reprogramming and Vulnerabilities in Cancer
Costas A. Lyssiotis et al.
CANCERS (2020)
Six1 Overexpression Promotes Glucose Metabolism and Invasion Through Regulation of GLUT3, MMP2 and Snail in Thyroid Cancer Cells
Chuanjia Yang et al.
ONCOTARGETS AND THERAPY (2020)
JNK and Autophagy Independently Contributed to Cytotoxicity of Arsenite combined With TetrandrineviaModulating Cell Cycle Progression in Human Breast Cancer Cells
Bowen Yu et al.
FRONTIERS IN PHARMACOLOGY (2020)
Targeted Degradation of Glucose Transporters Protects against Arsenic Toxicity
Marco Jochem et al.
MOLECULAR AND CELLULAR BIOLOGY (2019)
The simpler, the better: oral arsenic for acute promyelocytic leukemia
Hong-Hu Zhu et al.
BLOOD (2019)
Pathways of arsenic uptake and efflux
Luis D. Garbinski et al.
ENVIRONMENT INTERNATIONAL (2019)
The Prognosis Of Peroxiredoxin Family In Breast Cancer
Gang Wang et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Glucose Transporter 3 Is Essential for the Survival of Breast Cancer Cells in the Brain
Min-Hsun Kuo et al.
CELLS (2019)
Role of Cytosolic 2-Cys Prx1 and Prx2 in Redox Signaling
Yosup Kim et al.
ANTIOXIDANTS (2019)
Glucose transporters in cancer - from tumor cells to the tumor microenvironment
Pierre-Benoit Ancey et al.
FEBS JOURNAL (2018)
Mitochondrial redox sensing by the kinase ATM maintains cellular antioxidant capacity
Yichong Zhang et al.
SCIENCE SIGNALING (2018)
Low-level arsenic causes proteotoxic stress and not oxidative stress
Matthew Dodson et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
Mitochondrial redox sensing by the kinase ATM maintains cellular antioxidant capacity
Yichong Zhang et al.
SCIENCE SIGNALING (2018)
Antitumor activity of arsenite in combination with tetrandrine against human breast cancer cell line MDA-MB-231 in vitro and in vivo
Bo Yuan et al.
CANCER CELL INTERNATIONAL (2018)
Arsenic trioxide preferentially binds to the ring finger protein PML: understanding target selection of the drug
Cao Kaiming et al.
METALLOMICS (2018)
Peroxiredoxin 1 interacts with and blocks the redox factor APE1 from activating interleukin-8 expression
Hassan Nassour et al.
SCIENTIFIC REPORTS (2016)
Identification of Arsenic Direct-Binding Proteins in Acute Promyelocytic Leukaemia Cells
Tao Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Systematic identification of arsenic-binding proteins reveals that hexokinase-2 is inhibited by arsenic
Hai-nan Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Metallothionein blocks oxidative DNA damage induced by acute inorganic arsenic exposure
Wei Qu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2015)
Peroxiredoxin-1 protects estrogen receptor alpha from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer
Patrick C. O'Leary et al.
BREAST CANCER RESEARCH (2014)
Profiling metabolic networks to study cancer metabolism
Karsten Hiller et al.
CURRENT OPINION IN BIOTECHNOLOGY (2013)
Role for Prdx1 as a specific sensor in redox-regulated senescence in breast cancer
B. Turner-Ivey et al.
ONCOGENE (2013)
Protein Glutathionylation in the Regulation of Peroxiredoxins: A Family of Thiol-Specific Peroxidases That Function As Antioxidants, Molecular Chaperones, and Signal Modulators
Ho Zoon Chae et al.
ANTIOXIDANTS & REDOX SIGNALING (2012)
Glucose transporters in cancer metabolism
Kehinde Adekola et al.
CURRENT OPINION IN ONCOLOGY (2012)
Expression of GLUT1 and GLUT3 Glucose Transporters in Endometrial and Breast Cancers
Anna Krzeslak et al.
PATHOLOGY & ONCOLOGY RESEARCH (2012)
Multiple Functions of Peroxiredoxins: Peroxidases, Sensors and Regulators of the Intracellular Messenger H2O2, and Protein Chaperones
Sue Goo Rhee et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Arsenic geochemistry and human health in South East Asia
Kathleen M. McCarty et al.
REVIEWS ON ENVIRONMENTAL HEALTH (2011)
Glut1 and Glut3 as Potential Prognostic Markers for Oral Squamous Cell Carcinoma
Fernanda Rocha Rojas Ayala et al.
MOLECULES (2010)
Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity
Juxiang Cao et al.
EMBO JOURNAL (2009)
Sodium arsenite induces ROS generation, DNA oxidative damage, HO-1 and c-Myc proteins, NF-κB activation and cell proliferation in human breast cancer MCF-7 cells
Ruben Ruiz-Ramos et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2009)
Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy
A Ghavamzadeh et al.
ANNALS OF ONCOLOGY (2006)
Arsenic trioxide uptake by hexose permeases in Saccharomyces cerevisiae
ZJ Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Spatial redox regulation of a critical cysteine residue of NF-κB in vivo
T Nishi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Reversible inactivation of the tumor suppressor PTEN by H2O2
SR Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
